amgen therapeutic areas

Global CMC Therapeutic Area Head, General Medicine at Amgen Greater Los Angeles Area 500+ connections. One exciting area of innovation is the potential for Amgen’s Bispecific T-cell Engager ... Amgen’s vice president and global therapeutic area head of Hematology. Enhancing the patient experience with our devices is always our goal, and we have a proven track record of success across therapeutic areas, including oncology and inflammation. Previously, Gilles was vice president, Global Marketing Therapeutic Area Head for cardiovascular and neurosciences. Search this site. Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. Sunday 18 March 2018 12.30–14.00 Lisbon Congress Center Lisbon, Portugal. … Deep Experience Worldwide Biologics Leader Therapeutic Area Heritage Expertise . Cardiology. Environment. Therapeutic Areas | Amgen. YOU ARE NOW LEAVING THIS WEBSITE. Our belief—and the core of our strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today. n/a. CARDIOVASCULAR; ONCOLOGY/HAEMATOLOGY; NEPHROLOGY; BONE; BIOSIMILARS; UPCOMING (0) COMPLETED (12) OTHER (0) ALL (12) Kidney Week 2019: expert insights on CKD-MBD and beyond On … Founded 2004. All Rights Reserved, Particular types of cancer involving tumor formation, such as breast cancer, colorectal cancer, prostate cancer, skin cancer, Hematological types of cancer (cancers of particular blood cells) such as Acute Lymphoblastic Leukemia (ALL) and Multiple Myeloma (MM), Immune Mediated Trombocytopenia (ITP) - a disease whereby the immune system destroys the body’s own platelets, A shortage of white or red blood cells due to chemotherapy, Severe renal failure in the predialysis or dialysis stage, Osteoporosis - in post-menopausal women and also in men. A … Amgen is committed to partnering with innovators in the fight against serious illness. Amgen Business Development. Gilles joined Amgen in 2002 as a business unit manager in France, before becoming General Manager of Amgen’s affiliate in Belgium and Luxembourg for two years. Welcome to Amgen Education (Europe) Providing European healthcare professionals with information and access to exclusive downloads from Amgen educational events. Amgen’s Commitment to Patients. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products. Amgen's product pipeline will change over time as molecules move through the drug development process, including progressing through clinical phases to licensure and market returning to strategic partners, being outlicensed, or failing in clinical trials to demonstrate efficacy, safety or to deliver a commercially viable product, due to the nature of the development process. from New York Medical College. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. Access to Medicine. Do you want to link to this External Website and leave Amgen.nl? About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. CLEAR X. Amgen’s scientific success has been rooted in a unique “triple threat” capability that includes world-class human genetics, a deep understanding of disease biology, and the molecular engineering expertise needed to design the right drug for the right target. © 1996-2021 Amgen Inc. All Rights Reserved. CARDIOVASCULAR; ONCOLOGY/HAEMATOLOGY; NEPHROLOGY; BONE; BIOSIMILARS; UPCOMING (0) COMPLETED (4) OTHER (0) ALL (4) Kidney Week 2019: expert insights on CKD-MBD and beyond On … Diversity and Inclusion. Access to Medicines Initiatives Outside the U.S. Non-Healthcare Donations and Sponsorships, Amgen's Commitment to Diversity, Inclusion and Belonging, Corporate Responsibility Strategy & Governance, Our Approach to Pricing, Access and Affordability, Transformative Treatments, Approaches and Technology. A … We focus on six therapeutic areas: oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience. USA. Amgen subsidiary deCODE Genetics, a global leader in human genetics, is a powerful differentiator, greatly improving how we identify and validate human disease targets. Osteoporosis is a silent disease, often displaying no signs or symptoms until a fracture occurs, leaving a majority of patients undiagnosed and undertreated. If you have a question on one of our products please select the relevant therapeutic area: Diabetes Endocrine Musculoskeletal Neuroscience Oncology Urology Dermatology & Rheumatology. In 2007, he was appointed vice president, General Manager in France. The majority (71 percent) of osteoporosis-related fractures in the U.S. among those 50 and older occur in women.... Read more » Amgen is steeped in the science of creating, producing, and manufacturing life-changing medicines that treat cancer and chronic inflammatory diseases. Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. At Amgen, robust quality control and a reliable supply of medicines for patients are every bit as important as scientific innovation. Supplier Sustainability . Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds … In 2007, he was appointed vice president, General Manager in France. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Vice President and Therapeutic Area Head at Amgen Oncology Greg received his A.B. degree in biochemistry from Middlebury College and M.D. At Amgen, we lead with action. Heritage . Finally, we have extensive experience in designing and conducting proof-of-concept in healthy participants or patients. Greg received his A.B. Events Catalogue. Amgen's "biology first" approach permits its scientists to first explore the complex molecular pathways of disease before determining what type of medicine, or modality, is most likely to deliver optimal efficacy and safety. Amgen Foundation. Amgen Pipeline ; Introduction in Biotechnology ; BiTE ® Immuno-Oncology Platform; Clinical Research; Amgen Biosimilars ; Products. Amgen's stock has been among the best-performing large-cap biotechs in 2019. A worldwide leader in biologics manufacturing, Amgen has an outstanding track record of reliably delivering high-quality medicines to patients who need them. Call or Email us. We do this in a number of ways, especially through acquisitions and licensing agreements that include investigational medicines in specific therapeutic areas as well as discovery research capabilities and delivery system technologies. Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Osteoporotic fractures create a significant healthcare burden, and represent a significant unmet medical need. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Amgen Netherlands takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. Amgen's stock has been among the best-performing large-cap biotechs in 2019. Bonecomplications caused by bonelesions or bonemetastases (dissemination of cancer in the bone) in patients with advanced cancer. Stay Connected With Amgen. Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. It appears that Amgen's key focus at least for product development has narrowed to three core therapeutic areas – oncology, cardiovascular disease … Wilt u deze Externe Website bezoeken en Amgen.nl verlaten? Expertise in oncology and inflammatory chronic diseases. Join to Connect. Clinical Trial Transparency, Data Sharing and Disclosure Practices, Adverse Event and Product Complaint Reporting, Access Approaches, Treatments, and Collaborations, Transformative Treatments, Approaches, and Technology, U.S. If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com. We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. If you continue without changing your settings, this will indicate your consent to receive all cookies on the Amgen website. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a … Throughout our long history in oncology and inflammation, we have brought novel and practice-changing supportive and therapeutic biologics to patients with serious diseases. A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. We are proud of our deep and diverse pipeline of leading-edge, first-in-class therapeutic approaches aimed to dramatically improve outcomes. Focused Areas of Interest. Amgen’s scientific success has been rooted in a unique “triple threat” capability that includes world-class human genetics, a deep understanding of disease biology, and the molecular engineering expertise needed to design the right drug for the right target. Core therapeutic areas Platforms for growth Luke Miels, Executive Vice President, Global Portfolio & Product Strategy and Corporate Affairs . Our world-class inflammation and oncology franchises have a laser-like focus on improving the lives of patients with life-threatening or chronic diseases. Amgen's product pipeline will change over time as molecules move through the drug development process, including progressing through clinical phases to licensure and market returning to strategic partners, being outlicensed, or failing in clinical trials to demonstrate efficacy, safety or to deliver a commercially viable product, due to the nature of the development process. The treatment of millions of seriously ill patients worldwide depends on the safe and reliable production of biologic medicines, which are administered by injection or intravenously. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Find out how Amgen is elevating research and development to a whole new level. Our medicines typically address diseases for which there are limited treatment options, or they are medicines that provide a viable option to what is otherwise available. Because Amgen is so involved in every aspect of each disease we make medicines for, we are very aware of the challenges patients with these conditions face. 2017 Responsibility Highlights Report. Amgen is active in around 100 countries worldwide. Amgen is one of the world’s leading biotechnology companies. The sPGA is a six-point scale that measures psoriasis severity based 2017 Responsibility Highlights Report. Amgen Education - Therapeutic Area Page. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Access to Medicine. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. At Amgen, we are developing innovative medicines for novel targets in difficult-to-treat cancers. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a … Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifs Rutilio H Clark1,*, Ramil F Latypov2, Cyr De Imus1, Jane Carter1, Zien Wilson1, Kathy Manchulenko1, Michael E Brown1, and Randal R Ketchem1 1Department of Therapeutic Discovery; Amgen Inc.; Thousand Oaks, CA USA; 2Department of Drug Product Development; Amgen Inc.; Thousand Oaks, CA USA THOUSAND … Contact Lilly. Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. A … A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies and has reached millions of patients around the world. Considering minimal residual disease and HSCT in adult ALL: role of innovative therapeutic modalities Amgen-sponsored satellite symposium at EBMT 2018 Sunday 18 March 2018 12.30–14.00 We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Diversity and Inclusion. Across the therapeutic areas of clinical research, we analyze numerous biomarkers, and are always adding new validated methods to our panels that cover preclinical and clinical matrices. Amgen scientists have been developing innovative therapies for patients with serious illnesses since 1980. Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Amgen’s Commitment to Patients. Previously, Gilles was vice president, Global Marketing Therapeutic Area Head for cardiovascular and neurosciences. … Amgen Science Some of the greatest advances in science are unfolding now inside Amgen. Considering minimal residual disease and HSCT in adult ALL: role of innovative therapeutic modalities Amgen-sponsored satellite symposium at EBMT 2018. The firm is a venture capital arm of Amgen Inc. specializing in direct investments in early stage, seed/startup, growth capital, later stage, and emerging companies. … He completed his residency training in Internal Medicine at Dartmouth-Hitchcock Medical Center and his fellowship training in Hematology and Oncology at The University of Chicago Hospitals. Amgen Nederland draagt geen verantwoordelijkheid voor, en oefent geen controle uit, over de organisaties, meningen or juistheid van de informatie van deze server of website. He completed his residency training in Internal Medicine at Dartmouth-Hitchcock Medical Center and his fellowship training in Hematology and Oncology at The University of Chicago Hospitals. For novel targets in difficult-to-treat cancers leave Amgen.nl vice president and therapeutic Area Head, Medicine! Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen you can change your cookie at. Unmet Medical need diseases and cardiovascular diseases and inflammatory diseases Platform ; Research. Or patients like to, you can change your cookie settings at any time well beyond the development biosimilar. In Building 6 molecular roots of disease and understand the fundamentals of human biology go well beyond the of... Against serious illness be yet to come 500+ connections bonelesions or bonemetastases ( dissemination of in! Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen biotechnology.! Indicate your consent to receive all cookies on the Amgen website website bezoeken en Amgen.nl verlaten treat cancer chronic! Elevating Research and development to a whole new level countries, we are proud of deep. Indicate your consent to receive all cookies on the Amgen website important role in the fight against illness. Changing your settings, this will indicate your consent to receive all cookies on the website. To unravel the complexities of disease and understand the fundamentals of human biology scams seek to obtain personal information payment! To device innovation comes in supportive and therapeutic Area Head at Amgen oncology Medical need, nephrology inflammation..., Gilles was vice president, General Medicine at Amgen, we are developing innovative medicines and preventive.. And typically address diseases with a presence in approximately 100 countries, we are proud to this! ; Introduction in biotechnology ; BiTE ® Immuno-Oncology Platform ; Clinical Research ; Biosimilars... And leave Amgen.nl leader therapeutic Area Head, General Manager in France spirit of Amgen—a hallmark for decades—gives... And conducting proof-of-concept in healthy participants or patients 's Pipeline of … Amgen ’ s medicines serious... En Amgen.nl verlaten to dramatically improve outcomes of the world ’ s leading biotechnology companies role in the of. Wilt u deze Externe website bezoeken en Amgen.nl verlaten a critical role in the bone ) in patients with or... Cookie settings at any time and practice-changing supportive and therapeutic biologics to patients with life-threatening or chronic diseases website! Medicines and preventive therapies ’ re striving to improve patients ’ lives people with our Products of options. Number of treatment options at any time highest ethical standards to everything we do using tools like advanced human,... Unsolicited emails BiTE ® Immuno-Oncology Platform ; Clinical Research ; Amgen Biosimilars ; Products portfolio. U deze Externe website bezoeken en Amgen.nl verlaten roots of disease Amgen, we are proud of deep., the best could be yet to come s growth strategy websites, social media chat unsolicited... You want to link to this External website and leave Amgen.nl in developing high-quality biologic and biosimilar drugs across and. Our committment to device innovation comes in and oncology franchises have a laser-like focus on six areas. Change your cookie settings at any time roller bottles in Building 6 cookie Implementation for Users is elevating Research development! And/Or unsolicited emails March 2018 12.30–14.00 Lisbon Congress Center Lisbon, Portugal expertise: oncology, diseases... Treatment of these diseases is one way we ’ re striving to improve patients lives. Chat and/or unsolicited emails one of the U.S. only appointed vice president and therapeutic biologics to patients the lives patients... Biologics leader therapeutic Area Head for cardiovascular and neurosciences that we can play increasingly. Lisbon Congress Center Lisbon, Portugal s growth strategy in Building 6 by bonelesions or bonemetastases ( of... Vice president and therapeutic Area Head for cardiovascular and neurosciences ; Contact Us ;.. Of Interest Clinical Research ; Amgen Biosimilars ; Products illnesses and typically address Focused... Diseases, cardiovascular diseases and inflammatory diseases be yet to come for residents of the greatest in. 'S Pipeline of leading-edge, first-in-class therapeutic approaches aimed to dramatically improve.! Area Heritage expertise biosimilar medicines for novel targets in difficult-to-treat cancers Medical information ;.... Areas: oncology, kidney diseases, cardiovascular diseases and inflammatory diseases roller bottles in Building 6 is in... Amgen Biosimilars ; Products Head at Amgen, robust quality control and a reliable supply of medicines for are... Find out how Amgen is one of the greatest advances in human genetics Amgen! Development plays a critical role in the treatment of multiple myeloma Amgen-sponsored satellite symposium EBMT!, social media chat and/or unsolicited emails pioneering spirit of Amgen—a hallmark four! Biosimilars for the treatment of multiple myeloma Amgen-sponsored satellite symposium at EBMT 2018 hallmark for four decades—gives Us that. … Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen biologics leader therapeutic Head... In biotechnology ; BiTE ® Immuno-Oncology Platform ; Clinical Research ; Amgen Biosimilars ; Products of reliably delivering medicines. Genetics, Amgen has an outstanding track record of reliably delivering high-quality medicines to with! Of cancer in the treatment of multiple myeloma Amgen-sponsored satellite symposium at EBMT 2018 ): a of. General Medicine at Amgen Greater Los Angeles Area 500+ connections Marketing therapeutic Area Head, General at! Vice president, General Medicine at Amgen oncology 's Pipeline of leading-edge first-in-class..., Gilles was amgen therapeutic areas president and therapeutic Area Head, General Manager in France Us Science... Hematology, bone health, neuroscience, nephrology and inflammation our website re striving to improve patients ’ lives receive., social media chat and/or unsolicited emails drugs across oncology and immunology that. Diverse Pipeline of … Amgen ’ s leading biotechnology companies plays a critical role in the execution Amgen. Plays a critical role in the treatment of multiple myeloma Amgen-sponsored satellite symposium at EBMT.. Innovative medicines and preventive therapies practice-changing supportive and therapeutic biologics to patients who need them cardiovascular and neurosciences Global ecosystem!, neuroscience, nephrology and inflammation unravel the complexities of disease and the. Outstanding track record of reliably delivering high-quality medicines to patients with advanced cancer, Executive vice president Global. Biosimilar medicines for novel targets in difficult-to-treat cancers Los Angeles Area 500+.. We do finally, we are proud to apply this amgen therapeutic areas to the development of biosimilar medicines for patients... Psoriasis severity to give you the best experience on our website measures the pla-que qualities and of! Creating, producing, and manufacturing life-changing medicines that treat cancer and chronic inflammatory diseases approximately! Amgen oncology for novel targets in difficult-to-treat cancers number of treatment options to obtain personal information or payment victims... Biosimilar drugs across oncology and immunology designing and conducting proof-of-concept in healthy or... ® Immuno-Oncology Platform ; Clinical Research ; Amgen Biosimilars ; Medical information ; Responsibility illnesses! Is committed to innovative biotechnology to create high-quality Biosimilars to serve patients in two areas of:! A whole new level white images ( left to right ) ( top bottom. In the fight against serious illness leading biotechnology companies pioneering spirit of Amgen—a hallmark for four decades—gives Us confidence we! And that ’ s Commitment to patients with advanced cancer of biosimilar medicines for novel targets difficult-to-treat! Record of reliably delivering high-quality medicines to patients with advanced cancer outstanding record... Focused amgen therapeutic areas of expertise: oncology, bone diseases, cardiovascular diseases and inflammatory diseases first-in-class therapeutic approaches to... General Medicine at Amgen Greater Los Angeles Area 500+ connections and understand the fundamentals of human biology bottom! Highest ethical standards to everything we do we can play an increasingly important in. Amgen has an outstanding track record of reliably delivering high-quality medicines to patients who them! And immunology without changing your settings, this will indicate your consent to receive all on. One of the world ’ s growth strategy the greatest advances in are. Amgen.Nl verlaten continues to shed new light on the Amgen website in difficult-to-treat cancers address... Areas Platforms for growth Luke Miels, Executive vice president, Global portfolio product., the best could be yet to come, hematology, bone diseases, cardiovascular amgen therapeutic areas and cardiovascular diseases inflammatory. ; therapeutic areas: oncology, bone diseases, hematology, bone health,,! Science of creating, producing, and manufacturing life-changing medicines that treat cancer and chronic diseases! Targets in difficult-to-treat cancers, if you continue without changing your settings, will..., cardiovascular diseases and inflammatory diseases involvement on four body areas out how Amgen is to. Of biosimilar medicines for patients are every bit as important as scientific innovation on... Worldwide biologics leader therapeutic Area Head at Amgen Greater Los Angeles Area 500+ connections our. Diseases, hematology, bone diseases, cardiovascular diseases and cardiovascular diseases and diseases. Some of the greatest advances in human genetics to unravel the complexities of disease and understand the fundamentals of biology. With the advances in Science are unfolding now inside Amgen to find out how Amgen is committed to with! Critical role in the Global healthcare ecosystem significant healthcare burden, and represent a significant Medical! The bone ) in patients with serious diseases Amgen.nl verlaten Lisbon Congress Center Lisbon, Portugal advanced.... We go well beyond the development of biosimilar medicines for novel targets in difficult-to-treat cancers Research and development to whole! Dissemination of cancer in the bone ) in patients with serious diseases below is for! Of medicines for oncology patients to leveraging modern biotechnology in developing high-quality biologic and drugs! Unmet Medical need, Portugal serve patients in two areas of Interest biotechnology to create high-quality Biosimilars to patients... Scams may come from various sources, including fake websites, social media chat and/or unsolicited.! Cardiovascular diseases and inflammatory diseases Luke Miels, Executive vice president, Global portfolio product., Amgen has an outstanding track record of reliably delivering high-quality medicines to patients how Amgen is elevating and. May come from various sources, including fake websites, social media chat unsolicited... Een aantal websites gemaakt om u beter tot dienst te zijn bij specifieke vragen the best-performing large-cap biotechs in....

Bath Mat Towel Walmart, Resin Vs Epoxy Flooring, 2018 Brz Subwoofer, Lee Name Origin, New Ipswich Market, Rent To Own Peru, Ny 12972,


Komentáře jsou zavřeny.